NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Medyria

Medyria

Private
WinterthurHealthcare & Life Scienceshttps://www.medyria.com/

Last Round

VC Round

Jul 16, 2025

Total Funding Raised

$10.33M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Medyria is a healthcare and life sciences company that has developed sensor-based medical devices designed to measure blood flow velocity.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

interventional cardiologycardiovascular devicesblood flow velocity sensormicrocathetercatheter navigationMedTechmedical sensorscatheter positioning systemOEM medical sensorsendovascular proceduresphysiological assessmentcardiac catheterizationcoronary physiologyradiation-free procedurescontrast-free procedures

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medyria Comps

Public and private peers based on sector, stage, and business model.

Medyria comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Medyria Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 16, 2025
Series BJan 10, 2023
Series BFeb 12, 2018
Series AJan 29, 2015

Key People

Founding team and executive leadership

Mauro Sette

Chief Executive Officer, Chief Technology Officer

Executive Team

Medyria Investors

Notable investors and investment history

Medyria investors
InvestorRounds
Verve VenturesSeries A, Series B
Yellowstone Holding AGSeries B
EFI Lake Geneva VenturesSeries B
Buenavista Equity PartnersVC Round
InnosuisseGrant
Venture KickAccelerator
Zurcher KantonalbankSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2025

    $1.87M raised in a VC round.

  • Mar 1, 2025

    Pilot clinical study launched for PyCath product with Clinical Accelerator.

Medyria Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medyria Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medyria's valuation, stock price, and market status.

Firmographic Details

HeadquartersWinterthur
Employee Range12
Year Founded2012
Last FundingJul 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.